Stay updated on Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe page shows Revision: v3.3.4 where previously v3.3.3 appeared.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a dedicated Locations section featuring Beijing Municipality as a location. The previous 'Beijing Municipality Locations' entry was removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThese updates are minor editorial notes about how PubMed publications are displayed and include a page revision tag; they do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse notice related to operating status; no other substantive trial details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe updates appear to be cosmetic, including minor formatting and small textual refinements, with no changes to the study's design, eligibility criteria, endpoints, or enrollment status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check102 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

Stay in the know with updates to Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.